Equities

22nd Century Group Inc

XXII:NAQ

22nd Century Group Inc

Actions
Consumer Staples Tobacco
  • Price (USD)1.73
  • Today's Change-0.10 / -5.46%
  • Shares traded780.17k
  • 1 Year change-99.00%
  • Beta1.4820
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.

  • Revenue in USD (TTM)32.20m
  • Net income in USD-64.68m
  • Incorporated2005
  • Employees64.00
  • Location
    22nd Century Group Inc8560 Main St Ste 4WILLIAMSVILLE 14221-7435United StatesUSA
  • Phone+1 (716) 270-1523
  • Fax+1 (716) 877-3064
  • Websitehttps://www.xxiicentury.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Chemomab Therapeutics Ltd - ADR0.00-24.22m9.09m20.00--0.0267-----42.37-42.370.0023.930.00----0.00-74.28---90.33--------------0.00------12.39------
Vaccinex Inc570.00k-20.25m9.24m37.00------16.20-63.98-63.981.23-2.590.0982--1.0015,405.41-348.91-262.29-1,283.74-------3,552.81-4,257.17---59.75----107.27-4.67-2.20---22.20--
Akari Therapeutics PLC (ADR)0.00-10.01m9.39m9.00---------2.04-2.040.00-0.03460.00----0.00-110.06-149.95-1,281.64-435.18--------------------43.61------
Chromocell Therapeutics Corp0.00-7.38m9.40m4.00---------1.28-1.280.00-1.120.00----0.00-9,746.19-----------------13.23---------200.20------
Cell MedX Corp70.00-96.91k9.51m0.00------135,879.50-0.0029-0.00290.00-0.00240.0015-------202.28-792.55-----685.71---138,442.90-3,681.84---3.17-----54.53--29.01------
Eterna Therapeutics Inc68.00k-21.68m9.68m8.00--4.34--142.41-4.08-4.080.01280.41280.0019--0.09888,500.00-60.69-169.05-75.78-223.00-173.53---31,864.71-682.61---33.190.7813-----68.8911.84---58.86--
22nd Century Group Inc32.20m-64.68m9.69m64.00------0.301-49.97-116.4729.49-3.090.45315.708.81503,187.50-76.94-46.78-105.06-54.18-27.00-2.11-169.81-107.950.4766-4.622.39---20.494.03-76.94--53.60--
Kazia Therapeutics Ltd (ADR)14.74k-13.37m9.75m12.00--1.07--661.79-0.8109-0.81090.00080.34530.0007--73.97---63.98-46.35-82.39-54.75-----90,714.45-497.17----0.1297--979.43-28.3118.19------
Medical Marijuana Inc-100.00bn-100.00bn9.77m----0.1052----------0.019-----------22.66---23.11--70.58---145.521.79--0.0479--26.3039.07141.59---0.016--
Weed Inc0.00-31.55k9.88m2.00--38.69346.13---0.0002-0.00020.000.00210.00----0.00-2.49-385.93-14.84-822.37-----------16.980.3488------97.93---59.13--
Organovo Holdings Inc242.00k-19.09m10.04m15.00--1.59--41.49-2.17-2.170.02750.62830.0143--4.4412,100.00-112.40-51.24-123.59-54.90-----7,886.36-1,269.78----0.00---75.33-39.60-50.76--5.99--
BioCardia Inc477.00k-11.57m10.12m16.00------21.21-0.5525-0.55250.0225-0.06770.0747--3.6129,812.50-181.08-107.34-414.21-154.17-----2,425.79-1,779.24---------64.72-5.262.82---28.89--
Galera Therapeutics Inc0.00-59.08m10.12m7.00---------1.42-1.420.00-2.410.00----0.00-168.38-83.69-227.94-97.54-----------4.787.60------5.05---29.84--
Guardion Health Sciences Inc12.25m158.03k10.14m9.0063.581.2457.170.82830.12430.12439.666.390.7292.365.831,360,951.000.9405-77.901.12-86.5544.0442.451.29-176.936.98--0.00--10.8567.03101.00---58.56--
Data as of Apr 26 2024. Currency figures normalised to 22nd Century Group Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.